Man­u­fac­tur­ing roundup: Fer­ring looks to scale up gene ther­a­py; Eu­roAPI looks to boost pro­duc­tion of pain med­i­cine

Fer­ring Phar­ma­ceu­ti­cals has been grant­ed a pri­or ap­proval sup­ple­ment for its gene ther­a­py Ad­sti­ladrin. This FDA okay will al­low Fer­ring to scale up pro­duc­tion of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER